33868-76-7

Usage

Synthesis Reference(s)

Tetrahedron Letters, 14, p. 4207, 1973 DOI: 10.1016/S0040-4039(01)87150-1

InChI:InChI=1/C12H14O2S2/c1-14-10-6-4-9(5-7-10)11(13)8-12(15-2)16-3/h4-8H,1-3H3

Upstream product

• 33895-75-9 N,N-Dimethyl-bis-3,3-(methylthio)-propen⁽²⁾-iminium⁽¹⁾-iodid 
• 30162-62-0 3-Cyclohexylamino-3-p-methoxyphenylpropen-methyldithioat 
• 74-88-4 methyl iodide 
• 21262-53-3 3-Benzylamino-3-(4-methoxy-phenyl)-propen-⁽²⁾-dithiosaeure-methylester 
• 32316-81-7 (Z)-3-Dimethylamino-3-(4-methoxy-phenyl)-dithioacrylic acid methyl ester 
• 75-15-0 carbon disulfide 
• 77-78-1 dimethyl sulfate 
• 100-06-1 1-(4-methoxyphenyl)ethanone 
• 32470-65-8 5-(4-Methoxyphenyl)-3-(methylthio)-1,2-dithiolium-iodid 
• 41501-69-3 3,3-dichloro-1-(4-methoxyphenyl)-2-propen-1-one 
• 5188-07-8 sodium thiomethoxide 

Downstream Products

• 78570-47-5 2-(4-methoxyphenyl)-4-(methylthio)-5,6,7,8-tetrahydroquinoline 
• 132058-95-8 3-(4-methoxybenzoyl)-2,5-diphenylpyrrole 
• 128951-27-9 4-(4-Methoxy-phenyl)-6-methylsulfanyl-pyran-2-one 
• 123150-29-8 2(3H)-<(E)-(4-Methoxybenzoyl)methylene>benzothiazole 
• 86967-39-7 2-(Bis-methylsulfanyl-methylene)-3-[2-(4-methoxy-phenyl)-2-oxo-eth-(E)-ylidene]-succinic acid dimethyl ester 
• 78570-37-3 2-methyl-4-(methylthio)-6-(4-methoxyphenyl)pyridine 
• 78227-71-1 (E)-1-(4-Methoxy-phenyl)-3-methylsulfanyl-hex-2-ene-1,5-dione 
• 78570-50-0 C₁₄H₁₅O₃S^(1-)*K⁽¹⁺⁾ 
• 78570-39-5 2,6-Bis-(4-methoxy-phenyl)-4-methylsulfanyl-pyridine 
• 78227-65-3 (E)-1,5-Bis-(4-methoxy-phenyl)-3-methylsulfanyl-pent-2-ene-1,5-dione 
• 78227-65-3 (E)-1,5-Bis-(4-methoxy-phenyl)-3-methylsulfanyl-pent-2-ene-1,5-dione 
• 81874-58-0 4-Ethoxy-3-(4-methoxy-benzoyl)-6-(4-methoxy-phenyl)-pyran-2-one 
• 2881-83-6 ethyl 4-methoxybenzoylacetate 
• 123559-08-0 2-(4-Methoxy-phenyl)-4,4-bis-methylsulfanyl-but-3-en-2-ol 

Relevant academic research and scientific papers

Synthesis of 2,4,5-Trisubstituted Oxazoles with Complementary Regioselectivity from α-Oxoketene Dithioacetals and β-(Methylthio)-β-(het)aryl-2-propenones

An efficient protocol for the synthesis of 2,5-substituted 4-acyloxazoles and the related 2,4-substituted 5-acyloxazoles with complementary regioselectivity from the corresponding α-oxoketene dithioacetals or β-(het)aryl/(methylthio)enone precursors has been reported. In the first protocol, the α-oxoketene dithioacetals or β-(methylthio)enones were converted to the corresponding α-bromo-β-(methylthio)enones followed by copper catalyzed inter/intramolecular annulation of these intermediates with various primary amides affording 2-(het)aryl/alkyl-4-(het)aroyl-5-(methylthio)/(het)aryloxazoles via concomitant formation of the C4-N and C5-O bond via enamide intermediates. In the second approach, the starting α-oxoketene dithioacetals or β-(methylthio)-β-(het)arylenones were subjected to base induced conjugate addition-elimination with various primary amides to furnish β-aroylenamides, which, on subsequent iodine catalyzed intramolecular oxidative C-H functionalization/C-O bond formation, afforded the corresponding regioisomeric 2-(het)aryl/alkyl-4-(methylthio)/(het)aryl-5-(het)aroyloxazoles in excellent yields. The methodology has also been extended for the synthesis of regioisomeric 4- or 5-aminooxazoles and 4- or 5-(n-butyl)oxazoles from the corresponding 4- or 5-(methylthio)oxazoles.

Transition metal free synthesis of multifunctional thiomethylated-benzenes from aryl/heteroaryl/cyclopropyl methyl ketones

A base-promoted strategic synthesis of various functionalized thiomethylated-benzenes has been established from aryl/heteroaryl/cyclopropyl methyl ketone. We can directly access the thiomethylated-benzene nucleus embedded with diverse functional group by

HETERO RING-FUSED PHENYL COMPOUNDS FOR INHIBITING TNIK AND MEDICAL USES THEREOF

The present disclosure provides the compound having inhibitory property against TNIK having a specific chemical structure or its pharmaceutically acceptable salt. The present disclosure also provides a composition comprising the compound or its pharmaceutically acceptable salt. The present disclosure also provides a medical use of the compound, its salt or the composition comprising the compound or its pharmaceutically acceptable salt for treating or preventing cancer. The present disclosure also provides a method of treatment or prevention of cancer comprising administering the compound, its salt or the composition comprising the compound or its salt to a subject in need of such treatment or prevention.

Synthesis of Partially Reduced Imidazo[1,2- a ]pyridines through an Unprecedented Base-Mediated (4+2) Cyclization

A water-mediated regioselective synthesis of 6,7-diaryl-5-oxo-2,3,5,6-tetrahydroimidazo[1,2-a]pyridine-6-carbonitriles was performed by the reaction of 2-[1-cyano-2,2-bis(methylsulfanyl)vinyl]benzonitrile with 1-aryl-2-(imidazolidin-2-ylidene)ethanones un

Synthesis and molecular docking studies of novel 2-(2-amino-6-phenyl-4-pyrimidinylamino) ethanol derivatives: Using ring-opening reactions of cyclic ketene-N,O-acetal

A series of six novel 2-(2-amino-6-phenyl-4-pyrimidinylamino) ethanol derivatives have been synthesized starting from commercially available substituted acetophenones via Oxoketene Dithioacetals with high yields. Ketene dithioacetal store act with 2-amino

Synthesis of β-amino-α,β-unsaturated ketone derivatives via sequential rhodium-catalyzed sulfur ylide formation/rearrangement

In the presence of a Rh(II) catalyst and β-(methylthio)-α,β-unsaturated ketones, 1-sulfonyl-1,2,3-triazoles can be converted into functionalized β-amino-α,β-unsaturated ketones via formation of α-imino rhodium carbene/sulfur ylide and subsequent rearrangement. The products decompose to useful 2-methylthiopyrrole derivatives conveniently in high yield.

Synthesis and anti-HCV determinant motif identification in pyranone carboxamide scaffold

Hepatitis C Virus exhibits high genetic diversity. The current treatment for genotype-1 with ～80% sustained virologic responses is a combination of pegylated interferon, ribavirin and boceprevir/telaprevir/simeprevir which is associated with several side

A convenient base-mediated synthesis of 3-aryol-4-methyl (or benzyl)-2-methylthio furans from α-oxo ketene dithioacetals and propargyl alcohols via domino coupling/annulations

A convenient base-mediated strategy to synthesize 3-aryol-4-methyl (or benzyl)-2-methylthio furans 2 (trisubstituted furans) has been developed through the domino coupling/annulations between available α-oxo ketene dithioacetals 1 and propargyl alcohols.

Copper-catalyzed trifluoromethylation of internal olefinic C-H bonds: Efficient routes to trifluoromethylated tetrasubstituted olefins and N-heterocycles

The functionalization of internal olefins has been a challenging task in organic synthesis. Efficient CuII-catalyzed trifluoromethylation of internal olefins, that is, α-oxoketene dithioacetals, has been achieved by using Cu(OH)2 as a catalyst and TMSCF3 as a trifluoromethylating reagent. The push-pull effect from the polarized olefin substrates facilitates the internal olefinic C-H trifluoromethylation. Cyclic and acyclic dithioalkyl α-oxoketene acetals were used as the substrates and various substituents were tolerated. The internal olefinic C-H bond cleavage was not involved in the rate-determining step, and a mechanism that involves radicals is proposed based on a TEMPO-quenching experiment of the trifluoromethylation reaction. Further derivatization of the resultant CF 3 olefins led to multifunctionalized tetrasubstituted CF3 olefins and trifluoromethylated N-heterocycles.

Synthesis and anti-HCV activity of 4-hydroxyamino α-pyranone carboxamide analogues

High genetic variability in hepatitis C virus (HCV), emergence of drug resistant viruses and side effects demand the requirement for development of new scaffolds to show an alternate mechanism. Herein, we report discovery of new scaffold I based on 4-hydr